Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check5 days agoChange DetectedThe page now shows revision: v3.7.0, replacing the previous revision: v3.6.6. This indicates a new version of the page content without changing the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new page revision tag v3.6.6 was added to the page metadata. The previous revision tag v3.6.5 was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedA new NIH grant/contract identifier (2018) was added to the study's identifiers, representing funding information for the trial.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.6.5 has been added to the page. The Plain Language Summary section was removed and the Revision: v3.6.4 entry was deleted, affecting how the trial information is presented.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision metadata on the page was updated to v3.6.4, replacing the previous v3.6.3. This reflects a new release/version of the page's underlying software.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.2 on the page, indicating a minor page update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.